![Red purple office building exterior](https://www.nortonrosefulbright.com/-/media/images/nrf/services/hero/red-purple-office-building-exterior.jpg?w=265&revision=b37faf22-8ccd-496a-b86c-16abc296e333&revision=5249781139247387904&hash=16D66CF5E15C3F983873655D37FCC1A0)
Publication
Competition Act amendments hub
Since 2022, there have been three waves of amendments to the Competition Act resulting in the most significant revisions to Canada’s competition laws in over a decade.
Global | Publication | May 2018
We have contributed to Getting the Deal Through: Pharmaceutical Antitrust.
Getting the Deal Through is an international publication that provides international expert analysis in key areas of law, practice and regulation for corporate counsel, cross-border legal practitioners, and company directors and officers. Different chapters are written by experts in each area, and Norton Rose Fulbright is proud to present our latest contributions in Pharmaceutical Antitrust 2018.
Publication
Since 2022, there have been three waves of amendments to the Competition Act resulting in the most significant revisions to Canada’s competition laws in over a decade.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023